Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nevro Corp (NY: NVRO )

4.290 -0.230 (-5.09%)
Official Closing Price Updated: 7:00 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nevro Corp

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Medical Device Firm Nevro Stock Is Trading Higher On Tuesday
Nevro stock rises as it gains CE Mark for its HFX iQ SCS system, the first with AI-based personalized pain relief. 2024 revenue outlook raised amid positive earnings. 
Via Benzinga
Peeling Back The Layers: Exploring Nevro Through Analyst Insights
Via Benzinga
Earnings Scheduled For November 11, 2024
Via Benzinga
A Look Ahead: Nevro's Earnings Forecast
Via Benzinga
Breaking Down Nevro: 10 Analysts Share Their Views
Via Benzinga
Assessing Nevro: Insights From 9 Financial Analysts
Via Benzinga
Evaluating Nevro: Insights From 8 Financial Analysts
Via Benzinga
Airbnb Reports Weak Earnings, Joins Cryoport, Tripadvisor, Lyft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! 
Via InvestorPlace
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss Nevro Stock
Via Benzinga
Assessing Nevro: Insights From 9 Financial Analysts
Via Benzinga
NVRO Stock Earnings: Nevro Beats EPS, Misses Revenue for Q2 2024
NVRO stock results show that Nevro beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
NVRO Stock Earnings: Nevro Beats EPS, Beats Revenue for Q1 2024
NVRO stock results show that Nevro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off
Via AB Newswire
Where Nevro Stands With Analysts
Via Benzinga
Why Nevro Stock Lagged the Market on Thursday
Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments. 
Via The Motley Fool
Analyst Scoreboard: 4 Ratings For Nevro
Via Benzinga
Nevro: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. 
Via Benzinga
What Analysts Are Saying About Nevro Stock
Via Benzinga
Forecasting The Future: 6 Analyst Projections For Nevro
Via Benzinga
Where Nevro Stands With Analysts
Via Benzinga
What 4 Analyst Ratings Have To Say About Nevro
Via Benzinga
Earnings Preview For Nevro
Via Benzinga
What 21 Analyst Ratings Have To Say About Nevro
Via Benzinga
Expert Ratings for Nevro
Via Benzinga
Why Shares of Nevro Are Down Wednesday
The medical device maker saw increased revenue, but earnings lagged estimates. 
Via The Motley Fool
Potential Turnaround Ahead for Nevro: Q2 Earnings, Guidance Lag Wall Street Estimates
Pain management company Nevro Corp (NASDAQ: NVRO) reported Q2 FY23 revenue of $108.8 million, up 4% Y/Y, missing the management guidance of $110 million-$112 million and  
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.